Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The immune system can be modulated by exposure to specific allergens, which are typically harmless substances that trigger an exaggerated immune response in susceptible individuals. This process is central to the development and management of allergic diseases, where the immune system's recognition and reaction to these allergens can be altered through various mechanisms, including immunotherapy and controlled allergen exposure. Controlled exposure to allergens aims to shift the immune response from a pathogenic Th2/IgE-dominated profile toward a more regulated or tolerant state, often involving increased regulatory T cell activity or IgG4 production.
Gradual exposure to increasing doses of specific allergens to induce immune tolerance. This involves shifting the immune response from a Th2/IgE-dominated profile to a more regulated state, often involving increased regulatory T cell activity or IgG4 production. Mechanisms include: altered cytokine production, induction of Tregs, B cell isotype switching, and reduced mast cell and basophil reactivity.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System (modulation via exposure to specific allergens).